Qualigen Therapeutics Inc (QLGN) USD0.001
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
- Add to watchlist
- This stock can be held in a
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
Annual & interim reports
Annual & interim reports are not available for this stock.
Financial results for the last 5 years
Values are quoted in the stock's local currency: US dollar.
Income Statement: | n/a | ||||
---|---|---|---|---|---|
Revenue: | n/a | ||||
Operating Profit / (Loss): | n/a | ||||
Net Interest: | n/a | ||||
Profit Before Tax: | n/a | ||||
Profit after tax from continuing operations: | n/a | ||||
Discontinued Operations: | |||||
Profit after tax from discontinuing operations: | n/a | ||||
Profit for the period: | n/a | ||||
Attributable to: | |||||
Equity holders of parent company: | n/a | ||||
Minority Interests / Other Equity: | n/a | ||||
Total Dividend Paid: | n/a | ||||
Retained Profit / (Loss) for the Financial Year: | n/a | ||||
Earnings per Share: | |||||
Basic: | n/a | ||||
Diluted: | n/a | ||||
Adjusted: | n/a | ||||
Dividend per Share: | n/a | ||||
Balance Sheet: | n/a | ||||
Assets: | |||||
Non-Current Assets: | |||||
Property, Plant & Equipment: | n/a | ||||
Intangible Assets: | n/a | ||||
Investment Properties: | n/a | ||||
Investments: | n/a | ||||
Other Financial Assets: | n/a | ||||
Other Non-Current Assets: | n/a | ||||
n/a | |||||
Current Assets: | |||||
Inventories: | n/a | ||||
Trade and Other Receivables: | n/a | ||||
Cash at Bank & In Hand: | n/a | ||||
Current Asset Investments: | n/a | ||||
Other Current Assets: | n/a | ||||
n/a | |||||
Other Assets: | n/a | ||||
Total Assets: | n/a | ||||
Liabilities: | |||||
Current Liabilities: | |||||
Borrowings: | n/a | ||||
Other Current Liabilities: | n/a | ||||
n/a | |||||
Net Current Assets: | n/a | ||||
Non-Current Liabilities: | |||||
Borrowings: | n/a | ||||
Provisions: | n/a | ||||
Other Non-Current Liabilities: | n/a | ||||
n/a | |||||
Other Liabilities: | n/a | ||||
Total Liabilities: | n/a | ||||
Net Assets: | n/a | ||||
Capital & reserves: | |||||
Share Capital: | n/a | ||||
Share Premium Account: | n/a | ||||
Other Reserves: | n/a | ||||
Retained Earnings: | n/a | ||||
Shareholders Funds: | n/a | ||||
Minority Interests / Other Equity: | n/a | ||||
Total Equity: | n/a |
a. Includes discontinued activities
b. Including assets due in more than one year
c. Not disclosed under IFRS
d. Total fixed assets
e. Includes borrowings
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.